ÂÜÀòÂÒÂ×

Lauren Stopfer is an accomplished professional in the field of proteomics and innovation, currently serving as the Executive Director of Proteomics & Innovation and Head of Proteomics & Immunopeptidomics at Aethon Therapeutics since January 2023. Prior to this role, Lauren held positions at BioNTech SE as a Senior Scientist and Scientist in Proteomics from March 2021 to January 2023. Lauren's academic background includes a Ph.D. in Biological Engineering from the Massachusetts Institute of Technology, where a significant focus was placed on cellular engineering during time spent as a PhD candidate and undergraduate researcher. Additional experience includes internships and teaching roles, alongside research contributions at institutions like the Mayo Clinic and the University of Wisconsin-Madison.